Trials / Completed
CompletedNCT04459507
A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
Registry of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 276 (actual)
- Sponsor
- Janssen Pharmaceutical K.K. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to describe the treatment patterns of participants receiving systemic treatment for of palmoplantar pustulosis (PPP) in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention will be administered as a part of this study. Both retrospective and prospective data will be collected. The retrospective data will be collected through participant charts and prospective data will be collected in accordance with clinical practice at the participant's clinic visits. |
Timeline
- Start date
- 2021-03-22
- Primary completion
- 2025-12-27
- Completion
- 2025-12-27
- First posted
- 2020-07-07
- Last updated
- 2026-02-10
Locations
39 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT04459507. Inclusion in this directory is not an endorsement.